ID: ALA4526051

Max Phase: Preclinical

Molecular Formula: C34H59N5O9

Molecular Weight: 681.87

Molecule Type: Unknown

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)OC[C@H]1[C@@H](C(=O)N(C)C)[C@H]([C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)ON1CCCN

Standard InChI:  InChI=1S/C34H59N5O9/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-18-26(41)46-23-24-27(32(44)37(2)3)30(48-39(24)21-17-20-35)31-28(42)29(43)33(47-31)38-22-19-25(40)36-34(38)45/h19,22,24,27-31,33,42-43H,4-18,20-21,23,35H2,1-3H3,(H,36,40,45)/t24-,27+,28-,29+,30+,31-,33+/m0/s1

Standard InChI Key:  SKKXVFSDMHRNAZ-DAYKWFGCSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 681.87

Molecular Weight (Monoisotopic): 681.4313

AlogP: 2.22

#Rotatable Bonds: 22

Polar Surface Area: 189.65

Molecular Species: BASE

HBA: 12

HBD: 4

#RO5 Violations: 2

HBA (Lipinski): 14

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 9.70

CX Basic pKa: 10.09

CX LogP: 1.96

CX LogD: 0.30

Aromatic Rings: 1

Heavy Atoms: 48

QED Weighted: 0.10

Np Likeness Score: 0.56

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]

Source

Source(1):

• Scientific Literature